Sedation in the Intensive Care Unit
Trial on The Efficacy of Sedation in Mechanically Ventilated Critically Ill Patients
2 other identifiers
interventional
126
1 country
1
Brief Summary
High-risk critically ill patients often require mechanical ventilation either to primarily support the respiratory function or when the ventilation is insufficient to maintain adequate gas exchanges as a result of other organ impairment. In order to tolerate this aggressive mechanical support, enhance patient synchrony with the ventilator, and relieve pain and anxiety, analgesia and sedation are provided. It is suggested that an inappropriate use of sedation and analgesia may prolong the duration of mechanical ventilation and increase the risk of specific adverse outcomes such as ventilator associated pneumonia. Despite the widespread use of sedation, little information is available concerning the effect of varying the level of sedation on patients' subsequent mental health. We designed a randomized controlled trial to investigate the efficacy of sedation with the goal of maintaining the patient cooperative and interactive compared to the administration of sedation with the goal of maintaining the patient sedated. The first goal will be achieved by a discontinuous injection of a sedative, while the second goal will be achieved by a continuous infusion of the same sedative. In both groups pain relief will be provided in the same fashion with equal endpoints on a pain scoring scale. Our primary aim is to investigate whether differences in the occurrence of post-traumatic stress disorders (PTSD), anxiety, and depression are related to the choice of sedation-analgesia strategies. Secondary endpoints include the length of ICU stay, as indicated by the time to discharge from the ICU, the time to separation from mechanical ventilation, the rates of pulmonary and extra-pulmonary complications, and hospital length of stay. These endpoints will be compared between the two groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3
Started Feb 2003
Typical duration for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2003
CompletedFirst Submitted
Initial submission to the registry
September 15, 2005
CompletedFirst Posted
Study publicly available on registry
September 22, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2007
CompletedJanuary 11, 2007
January 1, 2007
September 15, 2005
January 9, 2007
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Post-traumatic stress disorders (PTSD)
Anxiety
Depression
Secondary Outcomes (3)
Time to discharge from the Intensive Care Unit
Time to separation from mechanical ventilation
Rates of pulmonary and extra-pulmonary complications Hospital length of stay
Interventions
Eligibility Criteria
You may qualify if:
- Critically ill patients requiring mechanical ventilation
You may not qualify if:
- Neurological conditions or neuromuscular disease
- Chronic renal failure, liver failure
- Allergy to benzodiazepines or morphine
- Drug overdose
- Pregnancy
- Non-cooperative
- Treatment with HIV protease inhibitors or erythromycin
- Refusal of consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Genevalead
- Swiss National Science Foundationcollaborator
Study Sites (1)
Geneva University Hospitals
Geneva, 1211, Switzerland
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Miriam M Treggiari, MD
University Hospital, Geneva
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 15, 2005
First Posted
September 22, 2005
Study Start
February 1, 2003
Study Completion
January 1, 2007
Last Updated
January 11, 2007
Record last verified: 2007-01